BR100 Increased By (0.99%)
BR30 Increased By (0.38%)
KSE100 Increased By (1.06%)
KSE30 Increased By (1.14%)
BECO 5.39 Increased By ▲ 0.07 (1.32%)
BML 56.48 Increased By ▲ 1.39 (2.52%)
BOP 35.09 Increased By ▲ 0.05 (0.14%)
CNERGY 8.17 Increased By ▲ 0.08 (0.99%)
DCL 11.44 Increased By ▲ 0.08 (0.7%)
FCCL 57.55 Increased By ▲ 1.36 (2.42%)
FCSC 5.00 Decreased By ▼ -0.01 (-0.2%)
FFL 17.88 Increased By ▲ 0.20 (1.13%)
FNEL 1.25 Increased By ▲ 0.01 (0.81%)
HUMNL 11.17 Increased By ▲ 0.24 (2.2%)
KEL 8.54 Decreased By ▼ -0.03 (-0.35%)
KOSM 6.73 Increased By ▲ 0.24 (3.7%)
MLCF 106.91 Increased By ▲ 0.40 (0.38%)
NBP 198.50 Decreased By ▼ -1.26 (-0.63%)
PACE 11.07 Increased By ▲ 0.05 (0.45%)
PAEL 45.45 Increased By ▲ 0.45 (1%)
PIAHCLA 31.43 Increased By ▲ 2.86 (10.01%)
PIBTL 19.08 Increased By ▲ 0.81 (4.43%)
PPL 242.62 Decreased By ▼ -1.87 (-0.76%)
PRL 35.67 Increased By ▲ 0.73 (2.09%)
PTC 65.52 Decreased By ▼ -0.30 (-0.46%)
SEARL 94.54 Increased By ▲ 0.49 (0.52%)
SSGC 32.08 Increased By ▲ 1.25 (4.05%)
TELE 8.87 Increased By ▲ 0.17 (1.95%)
THCCL 65.66 Increased By ▲ 0.67 (1.03%)
TPLP 10.73 Increased By ▲ 0.47 (4.58%)
TREET 25.11 Increased By ▲ 0.24 (0.97%)
TRG 63.67 Increased By ▲ 0.31 (0.49%)
WAVES 10.70 Increased By ▲ 0.05 (0.47%)
WTL 1.25 Increased By ▲ 0.01 (0.81%)
World

Canada records second case of rare blood clot after AstraZeneca shot

  • The country is facing a third coronavirus wave, however, that has recently forced provinces to tighten restrictions.
Published April 18, 2021 Updated April 18, 2021 11:46am
By

TORONTO: Canadian health authorities said Saturday the country has recorded a second case of rare but serious blood clotting linked to AstraZeneca's Covid-19 vaccine, but still recommend the shot for use.

The patient, who lives in the western province of Alberta and received a version of the AstraZeneca vaccine supplied by the Serum Institute of India, "has received treatment and is recovering," Canadian health authorities wrote on Twitter.

Canada reported its first case of blood clotting associated with low platelets on Tuesday in a Quebec woman who received the same shot.

Blood clot formations linked to the AstraZeneca vaccine "remain very rare" and Canada still believes that the vaccine's benefits "outweigh the potential risks," Health Canada and the Public Health Agency of Canada said.

Canada's health authorities added that they would "continue to monitor the use of all #COVID19 vaccines closely and examine and assess any new safety concerns."

At the end of March Canada's National Advisory Committee on Immunization (NACI) recommended suspending the use of the AstraZeneca vaccine in people under the age of 55 while it evaluated the risks.

However Health Canada said Wednesday that according to its analysis, limiting the use of the vaccine to certain populations was not necessary for the moment.

After a slow start, Canada's vaccine campaign is gaining momentum.

To date, 23.3 percent of the Canadian population has received at least one vaccine dose according to the Covid-19 Tracker Canada website.

The country is facing a third coronavirus wave, however, that has recently forced provinces to tighten restrictions.

Ontario, which has the highest number of cases, announced Friday it would strengthen and extend lockdown measures until May 19, and also close its borders with the provinces of Quebec and Manitoba beginning Monday.

Canada has recorded more than 1.1 million cases of Covid-19 since the start of the pandemic and more than 23,500 deaths.

Comments

Comments are closed for this article.